Back to
GOLDMAN SACHS GROUP INC
QNCX
Showing 3 of 6 quarters
Position history for
GOLDMAN SACHS GROUP INC's holdings in QUINCE THERAPEUTICS INC
As of its Q1 2026 13F, Goldman Sachs Group held 16,064 shares of QNCX (Quince Therapeutics), worth $1,629. Goldman Sachs Group's 13F filings listed QNCX from Q4 2025 to Q1 2026, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$769,478
Total Shares Change
-229,695
Quarter-by-Quarter History